Sigyn Therapeutics, Inc.
OTC: SIGY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- James A. Joyce
- Employees
- 4
- Headquarters
- San Diego, United States
- IPO year
- 2021
- Market cap
- $56.2K
- Website
- https://www.sigyntherapeutics.com
Loading SIGY…
Loading profile data…Frequently asked questions about SIGY
What does Sigyn Therapeutics, Inc. (SIGY) do?
Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise currently in its development phase. The company's core innovation is Sigyn Therapy, an advanced blood purification system designed to overcome the limitations of existing drugs and medical devices used to treat severe inflammatory disorders. A key focus is on sepsis, which...
Where does SIGY trade?
Sigyn Therapeutics, Inc. (SIGY) trades on the Other OTC.
What sector is SIGY in?
Sigyn Therapeutics, Inc. (SIGY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sigyn Therapeutics, Inc.?
James A. Joyce is the chief executive officer of Sigyn Therapeutics, Inc. (SIGY).
Where is Sigyn Therapeutics, Inc. headquartered?
Sigyn Therapeutics, Inc. is headquartered in United States.
Does SIGY pay a dividend?
Sigyn Therapeutics, Inc. (SIGY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SIGY go public?
Sigyn Therapeutics, Inc. (SIGY) completed its initial public offering in 2021.